These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 1725053)

  • 41. ["It is not how old you are but how you are old"-Antiarrhythmic therapy in elderly patients].
    Gonska BD; Lewalter T; Israel CW
    Herzschrittmacherther Elektrophysiol; 2017 Mar; 28(1):1-2. PubMed ID: 28224226
    [No Abstract]   [Full Text] [Related]  

  • 42. ADVANCES IN ANTIARRHYTHMIC DRUGS.
    DIPALMA JR
    Listing Res Cardiovasc Field; 1964; 10():135. PubMed ID: 24547396
    [No Abstract]   [Full Text] [Related]  

  • 43. Preliminary observations on a new antiarrhythmic agent (Ro 2-5803).
    BREST AN; STRAUGHN J; SINGER A; LIKOFF W
    Am J Cardiol; 1960 Jun; 5():811-4. PubMed ID: 13804243
    [No Abstract]   [Full Text] [Related]  

  • 44. [Chinese expert consensus on clinical use of antiarrhythmic drugs].
    ;
    Zhonghua Xin Xue Guan Bing Za Zhi; 2023 Mar; 51(3):256-269. PubMed ID: 36925136
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antiarrhythmic action of synthetic oxytocin in anesthetized man.
    KATZ RL
    Experientia; 1963 Mar; 19():160-1. PubMed ID: 14031328
    [No Abstract]   [Full Text] [Related]  

  • 46. Editorial Commentary: Whither antiarrhythmic drug therapy?
    Dorian P
    Trends Cardiovasc Med; 2016 Oct; 26(7):603-5. PubMed ID: 27234355
    [No Abstract]   [Full Text] [Related]  

  • 47. miRNA-based antiarrhythmics after myocardial ischaemic injury: Authors' reply.
    Driessen HE; Boink GJJ; van Veen TAB
    Europace; 2018 Jun; 20(6):1058-1059. PubMed ID: 29040473
    [No Abstract]   [Full Text] [Related]  

  • 48. The Cardiac Arrhythmia Suppression Trial: Implications for nursing practice.
    Kellen JC; Ettinger A; Todd L; Brezsnyak ML; Campion J; McBride R; Thomas S; Corum J; Schron E
    Am J Crit Care; 1996 Jan; 5(1):19-25. PubMed ID: 8680488
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antiarrhythmic drug prescription in patients after myocardial infarction in the last decade. Experience of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico (GISSI).
    Avanzini F; Latini R; Maggioni A; Colombo F; Santoro E; Franzosi MG; Tognoni G
    Arch Intern Med; 1995 May; 155(10):1041-5. PubMed ID: 7748046
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antiarrhythmic therapy and survival following myocardial infarction.
    Cowan JC; Coulshed DS; Zaman AG
    J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S92-8. PubMed ID: 1725053
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Antiarrhythmic agents: current situation].
    Bonhorst D
    Rev Port Cardiol; 1995 May; 14(5):421-9, 362. PubMed ID: 7654403
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Preventive antifibrillatory treatment of sudden cardiac death in acute myocardial infarct].
    Thale J; Gülker H; Hindricks G; Haverkamp W; Pollock B; Buchwalsky R
    Z Kardiol; 1988; 77 Suppl 4():11-22. PubMed ID: 3062962
    [TBL] [Abstract][Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.